This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK875.00.

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly LLY ...

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

In my last column about the Novo Nordisk Foundation ... in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl In a new white paper from the World ...

Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug. Rates of cancer among people aged 24 and below ...

Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...

To own and operate hospitals and health care services in over 530 locations across Australia and globally.